FORMULATING AND ENGINEERING CONFIDENCE

Vectura is now part of global medical CDMO Phillips Medisize. By combining the strengths of both companies, we enhance our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical customers and to fulfill our shared vision of helping patients around the world live healthier lives.

Together, we now offer formulation, device design and combination product development, as well as manufacturing services, to support the growing global need for inhalation and nasal therapies. Our expertise spans small molecules, biologics, complex combinations and generic products for pMDI, DPI, nasal inhaler and nebulizer devices.

With our 60 years of CDMO experience and extensive global capabilities, pharmaceutical leaders collaborate with our 6,000+ scientists, engineers and experts across seven R&D innovation centers and 23 manufacturing facilities in 11 countries. Learn more by visiting our stand and www.phillipsmedisize.com.

Phillips-Medisize
2202 Carmichael Rd
Hudson, WI 54016
USA

Websitewww.phillipsmedisize.com

Products and Services

Vectura Services & Capabilities – Helping You Succeed

Download a summary of Vectura's integrated inhaled services and capabilities from pre-clinical development to commercialization. More Info

See a bit more about Vectura…

Watch this short video and see how our integrated services can support your inhaled development program. More Info

Spray-drying, Advanced Powder Blends and Liquid Formulations

With expertise in powder and liquid formulations, we can help customers overcome the challenges of inhaled formulation development for small molecules, biologics and complex combinations. More Info

Inhaled Device Flexibility for your Program

Vectura has development expertise across a range of platforms, including capsule- and blister-based DPIs, pMDIs and smart nebulizers. This allows a “device agnostic” approach to best meet the needs of the customer, their development program and, ultimately, the patient. More Info

Efficient Scale-Up and GMP Manufacturing

As products progress through clinical development phases, customers require confidence in process scalability, commercial–ready devices, and robust manufacturing capabilities. Vectura’s GMP facilities and integrated approach ensure seamless scale-up from laboratory and pilot scale, through to commercially-relevant scale, enabling effective transfer to commercial manufacturing. More Info

Webcast: Dry Powder Inhalers (DPI) – Key Considerations For Combination Product Development

Download this free webcast where Andreas Meliniotis, Director of Device Development, discusses the key considerations to reduce risk when developing dry powder inhalers and combination products from early clinical trials through to scale-up, providing insights for both novel and generic development programs. More Info

↑ Back to Top